Amishi Drugs

Amishi Drugs & Intermediates is an established Indian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and drug intermediates. Founded in 1987 and headquartered in Ahmedabad, Gujarat, the company has built a strong reputation as a leading producer of anti-diabetic medications, including Metformin HCl, Gliclazide, and Glimepiride. Their manufacturing facilities are WHO-GMP certified, ensuring compliance with international quality standards for global distribution. Beyond metabolic disorders, Amishi Drugs produces APIs for neurology and cardiovascular indications, such as Gabapentin and Pregabalin. The company operates primarily as a B2B supplier and contract manufacturer, supporting the global generic pharmaceutical industry with high-volume, high-quality chemical synthesis.